Christopher’s Weekly Kratom Tea Talks-Community Support Group-Episode 36 April 9, 2026
Quick recap This informal group discussion focused on kratom advocacy, regulatory updates, and personal experiences within the kratom community. Christopher shared news that a Kratom bill was pulled in Iowa and discussed ongoing efforts in Tennessee and Kentucky, while the group also discussed FDA developments, including a recently released dose-finding study on kratom safety. The conversation covered concerns about poor-quality products on the market containing unknown ingredients such as 7OH and pseudo-oxylone, with participants emphasizing the importance of transparency and proper labeling. The discussion also touched on personal health topics, including Twinkle's weight-loss journey and Madalyn's use of supplements such as ashwagandha and reishi, before concluding with a casual conversation about the weather and food preferences. Summary Kratom Legislation Updates Discussion The group discussed updates on kratom legislation, with Christopher sharing news that Senator Zimmer in Iowa had pulled the Kratom bill from the debate calendar, though he noted mixed sentiment in Iowa, with some supporting regulations over a ban. The conversation also touched on ongoing efforts in Tennessee and Kentucky regarding kratom legislation, with Christopher expressing hope that federal recognition of kratom's safety could help reduce state-level restrictions, particularly for kratom tea. Kratom Product Purity Challenges Christopher and Twinkle discussed the challenges of ensuring product purity and transparency in the regulated industry, particularly in the context of kratom products. They highlighted issues such as unlisted ingredients, potential contamination, and the presence of harmful substances like pseudoindoxyl and fentanyl. Christopher emphasized the importance of disclosure and clarity in product information, sharing past experiences with fraudulent lab results and customer complaints about unexpected contaminants. Both agreed on the need for independent testing to build trust and ensure consumer safety.